I am confident that things are moving forward with the trials, a slower pace than we would like but it's not like they are getting no candidates. I am also confident CYDY has access to funding to keep moving forward, again i'm not happy with the dilution that comes with it or the low stock price it is done at. I am confident that Tony know what he is doing and that the task is the same as what it always has been - develop pro140 and sell it. The thing that i am not happy about this the stock price being completely dis-connected with the potential. I feel dumb for holding this for the many years while shorts make money, Nader makes money and investment firms create low risk positions that have a much greater multiple than i will ever have. Sell at this SP? that would be even more dumb. There are just no signs of failing financially or clinically. This will get there - it's just going to take the time and money it needs. Do you really think CYDY will close shop? Be sold for less than $1/share? Spend 10 years getting through clinical trials? no on all of them. If it was a simple road Progenics would have kept Pro140.
News 
Market Data 
Discover 
